Your browser doesn't support javascript.
loading
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis).
Malagoli, Piergiorgio; Dapavo, Paolo; Pavia, Giulia; Amoruso, Fabrizio; Argenziano, Giuseppe; Bardazzi, Federico; Burlando, Martina; Carrera, Carlo G; Damiani, Giovanni; Dini, Valentina; Girolomoni, Giampiero; Guarneri, Claudio; Loconsole, Francesco; Narcisi, Alessandra; Sampogna, Francesca; Travaglini, Massimo; Costanzo, Antonio.
Afiliação
  • Malagoli P; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.
  • Dapavo P; Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.
  • Pavia G; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Amoruso F; Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
  • Argenziano G; Dermatology Unit, Azienda Ospedaliera di Cosenza, Italy.
  • Bardazzi F; Department of Dermatology, 'Luigi Vanvitelli' University School of Medicine, Naples, Italy.
  • Burlando M; Dermatology Unit, Department of Specialistic, Diagnostic and Experimental Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Carrera CG; Section of Dermatology, Department of Health Sciences (DISSAL), IRCCS San Martino University Hospital, Genoa, Italy.
  • Damiani G; Fondazione Cà Granda IRCCS Maggiore Policlinico Hospital, Milan, Italy.
  • Dini V; Clinical Dermatology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milan, Italy.
  • Girolomoni G; Dermatology Unit, Department of Clinical and Experimental Medicine Ospedale Santa Chiara, Pisa, Italy.
  • Guarneri C; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
  • Loconsole F; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
  • Narcisi A; Department of Dermatology, University of Bari, Bari, Italy.
  • Sampogna F; Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
  • Travaglini M; Istituto Dermopatico Dell'Immacolata, (IDI) IRCCS, Rome, Italy.
  • Costanzo A; U.O.S.D. Dermatologica, Centro per la cura della psoriasi, Ospedale Perrino, Brindisi, Italy.
Dermatol Ther ; 35(8): e15608, 2022 08.
Article em En | MEDLINE | ID: mdl-35638250
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália